Formic Acid

Formic Acid

SCHEMBL2848717

CC[CH]C(=O)O.O=CO.O=CO.O=CO.O=CO.O=CO.O=CO.O=CO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
TDP1 Q9NUW8 2/20 0.37
MAPK1 P28482 1/20 0.37
FFAR3 O14843 2/20 0.35
CYP19A1 P11511 4/20 0.32
F7 P08709 3/20 0.32
F3 P13726 3/20 0.32
PPARA Q07869 3/20 0.32
PPARG P37231 3/20 0.32
OXER1 Q8TDS5 3/20 0.32
PTGS1 P23219 2/20 0.32
KMT2A Q03164 2/20 0.32
PPARD Q03181 2/20 0.32
RXRA P19793 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
HCAR2 Q8TDS4 2/20 0.32
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4256871 1.00 ALDH1A1 (0.37) ALDH1A1TDP1MAPK1FFAR3CYP19A1
SCHEMBL19276 0.91
SCHEMBL25384771 0.88
Formic Acid SCHEMBL4256859 0.74 TSHR (0.46) TDP1CYP19A1F7F3PPARA
Formic Acid SCHEMBL4249498 0.74 TSHR (0.46) TDP1CYP19A1F7F3PPARA
Formic Acid SCHEMBL3854971 0.72 EP300 (0.47) TDP1CYP19A1F7F3PPARA
Formic Acid SCHEMBL9849701 0.72 EP300 (0.47) TDP1CYP19A1F7F3PPARA
Propionic Acid SCHEMBL15260565 0.71 FFAR3 (0.71) ALDH1A1TDP1MAPK1FFAR3PPARA
Propionic Acid SCHEMBL9619152 0.71 FFAR3 (0.71) ALDH1A1TDP1MAPK1FFAR3PPARA
Propionic Acid SCHEMBL5342228 0.71 FFAR3 (0.71) ALDH1A1TDP1MAPK1FFAR3PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11603506-B2 Product comprising a plastic container and a substance composition SYMRISE AG (DE) 2023-03-14 US disclosed
US-20190225396-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2019-07-25 US disclosed
EP-3507352-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION Symrise AG (DE) 2019-07-10 EP disclosed
WO-2018041354-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2018-03-08 WO disclosed
US-9492367-B2 Mixture of fragrance compounds SYMRISE AG (DE) 2016-11-15 US disclosed
US-20160015614-A1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND UV-FILTER SUBSTANCES BEIERSDORF AG (DE) 2016-01-21 US disclosed
EP-2625255-B1 MIXTURE OF FRAGRANCE COMPOUNDS SYMRISE AG (DE) 2015-03-18 EP disclosed
US-8865634-B2 4-alkyl substituted pyridines as odiferous substances SYMRISE AG (DE) 2014-10-21 US disclosed
US-20130236402-A1 MIXTURE OF FRAGRANCE COMPOUNDS SYMRISE AG (DE) 2013-09-12 US disclosed
US-20120308486-A1 Fragrance and/or flavoring compositions containing dioxolanes SYMRISE AG (DE) 2012-12-06 US disclosed
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2010-05-27 US disclosed
US-20100069547-A1 Shape Memory Polymers Containing Degradation Accelerant SMITH & NEPHEW, INC. (US) 2010-03-18 US disclosed
EP-2142228-A1 SHAPE MEMORY POLYMERS CONTAINING DEGRADATION ACCELERANT Smith & Nephew, Inc. (US) 2010-01-13 EP disclosed
US-20090123392-A1 FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR SYMRISE GMBH & CO. KG (DE) 2009-05-14 US disclosed
WO-2008130916-A1 SHAPE MEMORY POLYMERS CONTAINING DEGRADATION ACCELERANT SMITH & NEPHEW, INC. (US) 2008-10-30 WO disclosed
US-7041162-B2 Ink composition and ink jet recording method FUJI PHOTO FILM CO., LTD. (JP) 2006-05-09 US disclosed
US-20040035322-A1 Ink composition and ink jet recording method FUJIFILM CORPORATION (JP) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130624-A1 4-ALKYL SUBSTITUTED PYRIDINES AS ODIFEROUS SUBSTANCES CYP4A22, CYP4X1, CYP4B1 ALDH1A1 24/4885TDP1 2078/4885MAPK1 1379/4885
US-20160015614-A1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND UV-FILTER SUBSTANCES TYR, NACA, AADAC ALDH1A1 228/4885TDP1 662/4885MAPK1 3840/4885
US-20120308486-A1 Fragrance and/or flavoring compositions containing dioxolanes FDFT1, DECR1, DOHH ALDH1A1 69/4885TDP1 1510/4885MAPK1 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.